We are confident in the proficiency and stability of our team, which has proven to be highly committed and has been key in contributing to Pharma Clinical’s know-how and in establishing a firm position in the CRO market.
 |
Dr. Dan Stolero, M.D, Pharma Clinical S.A.G, CEO/Medical Director
Dr. Stolero brings more than 23 years of hands-on experience in clinical studies including 16 years in the pharmaceutical industry. Dr. Stolero has served the pharmaceutical industry since 1988 and was involved in many international drug development projects with Bayer Healthcare. As a function of his role as Global Clinical Project Leader he was involved in the development of lipid-lowering drugs and conducted many clinical studies in hypertension, coronary artery disease, thrombosis, heart failure and asthma. Some of these studies were large scale global outcome studies. Since 2003 he has been leading Pharma Clinical SAG in Israel and is the owner of the Pharma Clinical group. Dr. Stolero received his MD from the Sackler Faculty of Medicine, Tel Aviv University in 1985. |
 |
Mrs. Sharon Tal, B.Sc., R.D, Business Development Manager
Mrs. Tal brings more than 20 years of work experience in the pharmaceutical industry, including leading international Pharma Companies, small biotech companies and CROs. During this period, Mrs. Tal held different key positions in the industry such as international clinical project leader for metabolic components, international project manager and business development manager. Mrs. Tal gained extensive experience in performing and managing phase I-IV studies in different therapeutic areas including: cardiovascular, metabolic, oncology, respiratory, dermatology and others. Mrs. Tal is a member of several international societies including the DIA and ACRP as well as local societies such as the Israel Society of Diabetes, the Israel Society for the Prevention of Arteriosclerosis Disease and the Israel Society for the Prevention of Obesity. Previously Mrs. Tal served as a member of the executive committee of the Israel Association for Clinical Trials. Mrs. Tal holds a B.Sc. degree in Biology, specializing in Nutrition from Hebrew University, Jerusalem in 1989 and is a RD by the Israeli Ministry of Health Authorities since Aug 1990. Currently Mrs. Tal is serving as the Business Development Manager at Pharma Clinical SAG. |
 |
Mrs. Vered Levy, M.Sc., B.Sc., Clinical Operations Manager
Mrs. Levy has two decades of experience in the pharmaceutical industry. During this period, Mrs. Levy held leading positions such as international study manager and local head of monitoring and study management. Since 2004, Mrs. Levy has been the Clinical Operation Manager (COM). Mrs. Levy has far-reaching experience in performing and managing clinical studies in diverse therapeutic areas. Mrs. Levy is a member of several international societies including the DIA and The Israeli Association for the Advancement of the Biomedical Research Community. Mrs. Levy is a lecturer at Haifa University for GCP training for investigational teams and at the Bioforum Applied Knowledge Center for qualifying new CRAs.Mrs. Levy received a B.Sc. degree in Animal Husbandry from the Hebrew University of Jerusalem in 1986 and a M.Sc. degree in Microbiology (immunology) from Bar Ilan University in 1989. Mrs. Levy joined Pharma Clinical in 1991. |
 |
Mrs. Liat Ben David, M.Sc., B.Sc, QA Manager
Mrs. Ben David is the head of the Quality Assurance unit of Pharma Clinical. Mrs. Ben David joined Pharma Clinical in 1999 as a CRA and became a lead CRA, EDC trainer and a Project Manager. Upon acquiring her M.Sc in Quality Assurance and Reliability Engineering, Mrs. Ben David was assigned to establish the Quality Assurance unit in Pharma Clinical. Mrs. Ben David is a BARQA member, lecturer at a CRA college and a member of the managing committee in the Israeli Association for the Advancement of the Biomedical Research Community (Ctrials). Mrs. Ben David received a M.Sc. for Quality Assurance and Reliability Engineering, from the Technion, Haifa in 2003 and a B.Sc. from the Faculty of Food Engineering & Biotechnology, Technion, Haifa in 1998. |